[Systemic lupus erythematosus and the central nervous system].
The central nervous system (CNS) manifestations of the chronic autoimmune disease systemic lupus erythematous (SLE) are reviewed. SLE-CNS dysfunction is broadly divided into neurologic and psychiatric clinical categories. The distinct clinical entities within these broad categories are fully described. Diagnostic criteria employed to verify the presence of SLE-CNS dysfunction, including laboratory serum and cerebral spinal fluid analyses as well as radiologic and other multimodality diagnostic tools, are compared and contrasted with respect to sensitivity and specificity.
Rojas
E
E
Servicio de inmunología clínica y alérgica, Hospital Regional Adolfo López Mateos, ISSSTE.
Orrea Solano
M
M
D000974:Antibodies, Antinuclear / Q000097:blood; D000918:Antibody Specificity; D001284:Atrophy; D001323:Autoantibodies / Q000276:immunology; D001327:Autoimmune Diseases / Q000150:complications* / Q000453:epidemiology / Q000523:psychology; D001921:Brain / Q000276:immunology / Q000473:pathology; D002493:Central Nervous System Diseases / Q000209:etiology* / Q000276:immunology; D002544:Cerebral Infarction / Q000209:etiology / Q000473:pathology; D006801:Humans; D007136:Immunoglobulins / Q000134:cerebrospinal fluid; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology / Q000523:psychology; D001523:Mental Disorders / Q000209:etiology* / Q000276:immunology; D009474:Neurons / Q000276:immunology; D012680:Sensitivity and Specificity; D014657:Vasculitis / Q000209:etiology / Q000473:pathology
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D007136:Immunoglobulins